Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA: 600521)
China flag China · Delayed Price · Currency is CNY
16.40
-0.37 (-2.21%)
Sep 6, 2024, 3:00 PM CST

Zhejiang Huahai Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
23,76521,59232,42932,24649,18022,824
Upgrade
Market Cap Growth
-8.82%-33.42%0.57%-34.43%115.47%64.98%
Upgrade
Enterprise Value
29,17127,59137,86935,43551,43824,897
Upgrade
Last Close Price
16.4014.5021.3321.0432.5315.00
Upgrade
PE Ratio
23.4525.4426.6661.8750.8236.58
Upgrade
PS Ratio
2.592.603.924.857.584.24
Upgrade
PB Ratio
2.782.624.194.767.313.95
Upgrade
P/FCF Ratio
20.2534.57-30.21-21.55176.2923.78
Upgrade
P/OCF Ratio
9.419.7426.1034.3631.6213.01
Upgrade
EV/Sales Ratio
3.193.324.585.337.934.62
Upgrade
EV/EBITDA Ratio
12.1513.0716.9833.7427.8720.10
Upgrade
EV/EBIT Ratio
18.4120.2524.0070.5237.4130.06
Upgrade
EV/FCF Ratio
24.8644.17-35.27-23.69184.3925.94
Upgrade
Debt / Equity Ratio
0.770.830.880.820.600.57
Upgrade
Debt / EBITDA Ratio
2.873.223.015.182.192.67
Upgrade
Debt / FCF Ratio
5.8810.98-6.32-3.6914.523.45
Upgrade
Asset Turnover
0.470.450.490.470.550.51
Upgrade
Inventory Turnover
1.090.991.041.051.041.00
Upgrade
Quick Ratio
0.810.740.910.901.390.87
Upgrade
Current Ratio
1.421.401.651.612.261.57
Upgrade
Return on Equity (ROE)
11.58%10.22%16.20%7.12%15.91%12.15%
Upgrade
Return on Assets (ROA)
5.07%4.63%5.87%2.21%7.25%4.91%
Upgrade
Return on Capital (ROIC)
6.19%5.75%7.35%2.72%8.65%6.15%
Upgrade
Earnings Yield
4.26%3.85%3.60%1.51%1.89%2.50%
Upgrade
FCF Yield
4.94%2.89%-3.31%-4.64%0.57%4.20%
Upgrade
Dividend Yield
1.22%1.38%1.13%0.48%0.61%1.21%
Upgrade
Payout Ratio
32.52%66.95%27.26%79.42%42.25%36.67%
Upgrade
Buyback Yield / Dilution
1.10%0.72%-1.80%1.30%-4.58%-5.70%
Upgrade
Total Shareholder Return
2.32%2.10%-0.67%1.78%-3.96%-4.49%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.